- Filed
- Aug 4, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Jul 31, 2025 | 11.4M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 290.4M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 283.13M sh |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $97.9K |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $97.9K |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $31.23K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $14.47K |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $38.5K |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $570.23K |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $578.75K |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $849.23K |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $857.75K |
| Current Assets | Q1 2025 · Mar 31, 2025 | $14.47K |
| Current Assets | Q1 2025 · Dec 31, 2024 | $38.5K |
| Total Assets | Q1 2025 · Mar 31, 2025 | $45.7K |
| Total Assets | Q1 2025 · Dec 31, 2024 | $84.2K |
| Net Income | Q1 2025 · Dec 31, 2024 | −$80.24K |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$80.24K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$22.62K |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | −$683.58K |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | −$603.34K |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $1.11K |